A Phase I/II Study of Dasatinib and Dacarbazine
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2013-12-16
- Target Recruit Count
- 50
- Registration Number
- NCT00597038
- Locations
- 🇺🇸
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, United States
🇺🇸H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2019-10-04
- Target Recruit Count
- 97
- Registration Number
- NCT00596011
- Locations
- 🇺🇸
LSU Health Sciences Center, Feist-Weiller Cancer Center, Shreveport, Louisiana, United States
🇺🇸Jefferson Medical College - Department of Urology, Philadelphia, Pennsylvania, United States
🇺🇸University of Chicago - Department of Surgery, Chicago, Illinois, United States
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
- Conditions
- Malignant Tumor of PeritoneumFallopian Tube CancerOvarian Cancer
- Interventions
- First Posted Date
- 2007-07-19
- Last Posted Date
- 2014-02-06
- Target Recruit Count
- 45
- Registration Number
- NCT00504257
- Locations
- 🇺🇸
Broward General Medical Center Cancer Center, Fort Lauderdale, Florida, United States
🇺🇸Women's Cancer Associates, Saint Petersburg, Florida, United States
🇺🇸Duke Cancer Institute, Durham, North Carolina, United States
Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2014-07-09
- Target Recruit Count
- 275
- Registration Number
- NCT00499109
- Locations
- 🇺🇸
Leesburg Regional Medical Center, Leesburg, Florida, United States
🇺🇸Center for Cancer Care & Research/Watson, Lakeland, Florida, United States
🇺🇸Johns Hopkins Sidney Kimmell Comprehensive Cancer Center, Baltimore, Maryland, United States
A Phase I/II Study of Sunitinib and Dacarbazine
- First Posted Date
- 2007-07-04
- Last Posted Date
- 2011-02-23
- Target Recruit Count
- 11
- Registration Number
- NCT00496223
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Phase II Trial of Pentostatin and Targeted Busulfan
- Conditions
- Hematologic Malignancies
- Interventions
- First Posted Date
- 2007-07-04
- Last Posted Date
- 2014-06-05
- Target Recruit Count
- 42
- Registration Number
- NCT00496340
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)
- First Posted Date
- 2007-07-03
- Last Posted Date
- 2012-03-27
- Target Recruit Count
- 33
- Registration Number
- NCT00495625
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
- Conditions
- Metastatic Pancreatic Carcinoma
- Interventions
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2012-11-08
- Target Recruit Count
- 20
- Registration Number
- NCT00480584
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)
- Conditions
- Non-Small-Cell Lung Carcinoma
- Interventions
- First Posted Date
- 2007-03-07
- Last Posted Date
- 2017-02-23
- Target Recruit Count
- 34
- Registration Number
- NCT00444015
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
- Conditions
- Brain Metastases
- Interventions
- First Posted Date
- 2007-02-21
- Last Posted Date
- 2017-02-23
- Target Recruit Count
- 10
- Registration Number
- NCT00437957
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States